Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endothelial progenitor cells and rheumatic disease modifying therapy.
Lo Gullo A, Aragona CO, Scuruchi M, Versace AG, Saitta A, Imbalzano E, Loddo S, Campo GM, Mandraffino G. Lo Gullo A, et al. Among authors: scuruchi m. Vascul Pharmacol. 2018 Sep;108:8-14. doi: 10.1016/j.vph.2018.05.007. Epub 2018 May 26. Vascul Pharmacol. 2018. PMID: 29842927 Review.
Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension.
Lo Gullo A, Mandraffino G, Rodríguez-Carrio J, Scuruchi M, Sinicropi D, Postorino M, Morace C, Giuffrida C, Sciortino D, Gallizzi R, Loddo S, Zito C, Squadrito G. Lo Gullo A, et al. Among authors: scuruchi m. Biomedicines. 2021 May 11;9(5):533. doi: 10.3390/biomedicines9050533. Biomedicines. 2021. PMID: 34064667 Free PMC article.
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy.
Toscano A, Cinquegrani M, Scuruchi M, Di Pino A, Piro S, Ferrara V, Morace C, Lo Gullo A, Imbalzano E, Purrello F, Squadrito G, Scicali R, Mandraffino G. Toscano A, et al. Among authors: scuruchi m. Biomolecules. 2022 Apr 9;12(4):562. doi: 10.3390/biom12040562. Biomolecules. 2022. PMID: 35454151 Free PMC article.
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units.
Scicali R, Mandraffino G, Scuruchi M, Lo Gullo A, Di Pino A, Ferrara V, Morace C, Aragona CO, Squadrito G, Purrello F, Piro S. Scicali R, et al. Among authors: scuruchi m. Biomedicines. 2022 Jul 15;10(7):1715. doi: 10.3390/biomedicines10071715. Biomedicines. 2022. PMID: 35885020 Free PMC article.
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units.
Scicali R, Mandraffino G, Di Pino A, Scuruchi M, Ferrara V, Squadrito G, Purrello F, Piro S. Scicali R, et al. Among authors: scuruchi m. Nutr Metab Cardiovasc Dis. 2021 Nov 29;31(12):3401-3406. doi: 10.1016/j.numecd.2021.08.034. Epub 2021 Aug 19. Nutr Metab Cardiovasc Dis. 2021. PMID: 34627693
51 results